PF
Pfizer Limited
PFIZER.BO · BSE
₹4,308.35 -6.22% (-₹285.90)
1M -5.76%
Market Cap ₹210.0B
P/E Ratio 28.57x
Div. Yield 1.63%
ROE 18.26%
Bulios Fair Price
₹3,412
20.8% downside
Current Price
₹4,308
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PFIZER.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
36 /100
Fair PEG 0.70x
P/S 8.17x
P/B 5.00x
Growth
31 /100
Declining Rev. growth 4.40%
FCF growth 1.04%
Book val. growth 13.76%
Profitability
100 /100
Strong Net margin 28.61%
Op. margin 34.40%
FCF margin 22.93%
Quality
84 /100
Excellent ROE 18.26%
ROA N/A
Asset turnover N/A
Debt
100 /100
Low Int. coverage 130.11x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
67 /100
Stable Rev. volatility 7.24%
EPS volatility 26.35%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PFIZER.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Meenakshi Nevatia
Employees
1,417
Headquarters
Mumbai
Upcoming events
11 NOV
Earnings
Upcoming earnings report